| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320986 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | CA2374247C Heterocyclic derivatives useful as anticancer agents |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |
| 01/22/2008 | CA2214321C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/17/2008 | WO2008008518A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008007459A1 3,4-dihalogenoisothiazole derivative and agent for controlling agricultural or horticultural plant disease |
| 01/17/2008 | WO2008007123A2 Pharmaceutical compounds |
| 01/17/2008 | WO2008006875A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | WO2008006873A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | WO2008006794A1 Indole compounds having affinity to the ep1 receptor |
| 01/17/2008 | WO2008006793A1 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006625A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/17/2008 | WO2008006479A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 01/17/2008 | WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 01/17/2008 | WO2008006257A1 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof |
| 01/17/2008 | WO2007084413B1 Methods for treating hepatitis c |
| 01/17/2008 | WO2007075297A3 Muscarinic agonists and methods of use thereof |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | US20080015358 Fluorination Process of Protected Aminothiazole |
| 01/17/2008 | US20080015235 Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses |
| 01/17/2008 | US20080015233 2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 01/17/2008 | US20080015225 Dimeric Piperidine Derivatives |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk) |
| 01/17/2008 | US20080015199 Triazolone derivatives |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080011191 Novel Azo Compound or Salt, Ink Composition Comprising Such Azo Compound, and Colored Article |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
| 01/17/2008 | CA2657601A1 Substituted indazoles |
| 01/17/2008 | CA2657552A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | CA2657350A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/17/2008 | CA2653698A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/17/2008 | CA2653589A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1877495A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/16/2008 | EP1877406A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
| 01/16/2008 | EP1877403A1 Mono-lysine salts of azole compounds |
| 01/16/2008 | EP1877400A1 Vanilloid receptor ligands and their use in treatments |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1877398A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 01/16/2008 | EP1877376A1 Novel compounds for treating inflammatory diseases |
| 01/16/2008 | EP1877369A2 Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 01/16/2008 | EP1877052A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1694673B1 Thiazole derivates |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1305311B1 Tartrate salt of thiazolidinedione derivative |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | CN101107246A Anti-trypanosomiasis agent |
| 01/16/2008 | CN101107245A Heteroaryl substituted piperazinyl-pyridine analogues |
| 01/16/2008 | CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists |
| 01/16/2008 | CN101104617A Dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 01/16/2008 | CN100361982C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 01/15/2008 | US7319109 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/10/2008 | WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/10/2008 | WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 01/10/2008 | WO2008003703A1 Indoles as 5-ht6 modulators |
| 01/10/2008 | WO2008003607A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 01/10/2008 | WO2008003452A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 01/10/2008 | WO2007136572A3 Antidiabetic bicyclic compounds |
| 01/10/2008 | WO2007134085A3 Isothiazolidines useful in the treatment of ocular hypertensive conditions |
| 01/10/2008 | WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 01/10/2008 | WO2007109334A3 Sip receptor modulating compounds and use thereof |
| 01/10/2008 | WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 01/10/2008 | WO2007050425A3 Lxr modulators |
| 01/10/2008 | WO2006098834A8 Crystalline forms of ziprasidone mesylate |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009620 Tricyclic Spacer Systems For Nonlinear Optical Devices |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080008655 Cyanine dye bioconjugates useful for diagnostic imaging and therapy; for photoacoustic imaging and detection of tumors; do not aggregate in solution, form starburst dendrimers, are capable of absorbing or omitting light in the near infrared region; Bis(ethylcarboxymethyl)indocyanine Dye |
| 01/10/2008 | CA2655694A1 1,4-substituted indoles useful for modulation of the 5-ht6 receptor |
| 01/10/2008 | CA2655680A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 01/10/2008 | CA2582605A1 Photochromic compound and optical functional material |
| 01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/09/2008 | EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders |
| 01/09/2008 | EP1874765A2 Urea derivatives methods for their manufacture and uses thereof |
| 01/09/2008 | EP1874758A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/09/2008 | EP1874752A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives |
| 01/09/2008 | EP1874745A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands |